---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-043808"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2023-08-22T23:59:59+00:00"
generated_at: "2026-06-11T05:41:22.105513+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tivic Health implements 1-for-100 reverse stock split to avoid Nasdaq delisting

## Summary
- 1-for-100 reverse stock split effective Aug 23, 2023; par value unchanged.
- Nasdaq had determined to delist TIVC due to bid price ≤ $0.10 for 10 days; appeal hearing set Sep 21, 2023.
- Company expects reverse split to bring bid price above $1.00 and regain compliance.
- No fractional shares issued; fractional shares rounded up; percentage ownership unchanged.
- Warrants, options, and equity awards proportionally adjusted; CUSIP changes to 888705 209.

## SEC filing metadata
- accession: 0000950170-23-043808
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2023-08-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/0000950170-23-043808-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/tivc-20230821.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-043808
- JSON: https://secwatch.observer/filing/0000950170-23-043808.json
- Plain text: https://secwatch.observer/filing/0000950170-23-043808.txt

## Key facts
- Governance Changes
  Valion Bio, Inc.: Board approved a 1-for-100 reverse stock split of common stock, effective August 23, 2023, to regain compliance with Nasdaq minimum bid price requirement (effective 2023-08-23).
  - Change: charter amendment
  - Effective: 2023-08-23
  source text: The Board of Directors of Tivic Health Systems, Inc., a Delaware corporation (the "Company"), has approved a reverse stock split of the Company's issued and outstanding shares of common stock, par value $0.0001 per share ("Common Stock"), at a ratio of 1-for-100 (the "Reverse Split").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/0000950170-23-043808-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.